InvestSMART

4DMedical Limited (ASX: 4DX) - Share Price

Current share price for 4DX : $4.250 0.19 (4.68%)+

4DMedical Limited (4DX), an ASX-listed company, is a Company engaged in medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging.

4DX General Information +

ASX Code 4DX
Website http://www.4dmedical.com
Industry/Sector Health Care Technology
Market Cap ($M) 2,540
4DX Share Price $4.250
Day High $4.260
Day Low $3.970
Last Close $4.060
4DX Share Price Movement $0.19 ( 4.68% )
Prices as at 16:40, 3 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

4DMedical Limited (4DX) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from 4DMedical Limited (4DX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

4DMedical Limited (4DX) price-sensitive announcements

4DX - 4DMedical receives TGA approval for CTVQ in Australia
4DMedical Limited, a leader in respiratory imaging technology, has received approval from
4DMedical Limited (4DX)
26 Jun 2026 | 8:18 AM
4DX - 4DMedical targets US$2.5B PE market entry for CTVQ
4DMedical Limited has announced the launch of CLEAR (Contrast-free Lung Evaluation for Acu
4DMedical Limited (4DX)
2 Jun 2026 | 8:30 AM
4DX - 4DMedical creates EU platform via contextflow acquisition
4DMedical Limited, a leader in respiratory imaging technology, announced its European expa
4DMedical Limited (4DX)
1 Jun 2026 | 9:31 AM
4DX - CTVQ enters US Outpatient Market via SimonMed 170 sites
4DMedical Limited has entered a commercial agreement with SimonMed Imaging, a leading outp
4DMedical Limited (4DX)
29 May 2026 | 10:03 AM

4DMedical Limited (4DX) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
4DMedical Limited (4DX)
ORDINARY FULLY PAID
 Health Care $2,540 Cleansing Notice 1 Jul 2026 2:52PM $4.125 $4.250 risen by 3.03%
4DMedical Limited (4DX)
ORDINARY FULLY PAID
 Health Care $2,540 Application for quotation of securities - 4DX 1 Jul 2026 2:48PM $4.130 $4.250 risen by 2.91%
4DMedical Limited (4DX)
ORDINARY FULLY PAID
 Health Care $2,540 Application for quotation of securities - 4DX 1 Jul 2026 2:46PM $4.130 $4.250 risen by 2.91%
4DMedical Limited (4DX)
ORDINARY FULLY PAID
 Health Care $2,540 Change of Director's Interest Notice LB JL 26 Jun 2026 3:59PM $4.185 $4.250 risen by 1.55%
4DMedical Limited (4DX)
ORDINARY FULLY PAID
 Health Care $2,540 Cleansing Notice 26 Jun 2026 3:55PM $4.185 $4.250 risen by 1.55%
4DMedical Limited (4DX)
ORDINARY FULLY PAID
 Health Care $2,540 Application for quotation of securities - 4DX 26 Jun 2026 3:50PM $4.185 $4.250 risen by 1.55%

4DX Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$29.41 -$13.70 33.00% 0.00 0.00 0.00% 0.0%
2024A -$33.66 -$10.30 -1.90% 0.00 0.00 0.00% 0.0%
2023A -$31.46 -$10.50 -10.90% 0.00 0.00 0.00% 0.0%

4DX Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
4DMedical Limited (4DX) $2,427M 0.3304 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Pro Medicus Limited (PME) $21,513M 0.3919 0.2545 0.2962 187.0391 149.0950 115.0254 0.27% 0.34% 0.45%

4DX Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 30.80 0.00
Market 0.29 13.10 1.15 0.63
Sector 0.70 20.50 1.62 2.64

4DX Directors

Name Position Start Date
Dr Andreas Fouras Chief Executive Officer, Managing Director 17 Dec 2012
Mr John Andrew Livingston Executive Director 7 Mar 2018
Dr Robert Alan Figlin Non-Executive Director 9 Dec 2016
Mr Julian Bernard Kingsley Sutton Non-Executive Director 15 Sep 2017
Dr Geraldine Bernadette McGinty Non-Executive Director 25 Sep 2023
Ms Lilian (Lil) Bianchi Non-Executive Director, Non-Executive Chairman 11 Dec 2019

4DMedical Limited (4DX) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
19 Jun 2026 SUTTON, Julian Buy Direct Shares 11,363 $4.400 $49,997.200
18 Jun 2026 SUTTON, Julian Buy Direct Shares 13,054 $3.830 $49,996.820
21 Jan 2026 FOURAS, Andreas Sell Indirect Shares 263,157 $3.800 $999,996.600

See all changes in directors' interest & trades for 4DMedical Limited (4DX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

4DX Management

Name Position
Matt Tucker Chief Commercial Officer
Hamish George Company Secretary

4DX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in 4DMedical Limited (4DX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
65,701,465 (13.31%) Helen Fouras

4DX Calendar of Events

Date Event
26 February 2027 Report (Interim)
25 September 2026 Report (Annual)
28 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.